News Image

Exploring NYSE:BMY's dividend characteristics.

By Mill Chart

Last update: Nov 22, 2023

BRISTOL-MYERS SQUIBB CO (NYSE:BMY) was identified as a stock worth exploring by dividend investors by our stock screener. NYSE:BMY scores well on profitability, solvency and liquidity. At the same time it seems to pay a decent dividend. We'll explore this a bit deeper below.

What does the Dividend looks like for NYSE:BMY

ChartMill assigns a Dividend Rating to every stock. This score ranges from 0 to 10 and evaluates the different dividend aspects, including the yield, the growth and sustainability. NYSE:BMY scores a 7 out of 10:

  • With a Yearly Dividend Yield of 4.48%, BMY is a good candidate for dividend investing.
  • BMY's Dividend Yield is rather good when compared to the industry average which is at 4.81. BMY pays more dividend than 95.61% of the companies in the same industry.
  • BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.65.
  • The dividend of BMY is nicely growing with an annual growth rate of 6.94%!
  • BMY has been paying a dividend for at least 10 years, so it has a reliable track record.

How do we evaluate the Health for NYSE:BMY?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NYSE:BMY scores a 5 out of 10:

  • With a decent Altman-Z score value of 2.32, BMY is doing good in the industry, outperforming 71.71% of the companies in the same industry.
  • BMY has a debt to FCF ratio of 3.22. This is a good value and a sign of high solvency as BMY would need 3.22 years to pay back of all of its debts.
  • BMY has a Debt to FCF ratio of 3.22. This is amongst the best in the industry. BMY outperforms 89.76% of its industry peers.

Evaluating Profitability: NYSE:BMY

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:BMY has earned a 8 out of 10:

  • Looking at the Return On Assets, with a value of 9.08%, BMY belongs to the top of the industry, outperforming 91.71% of the companies in the same industry.
  • With an excellent Return On Equity value of 28.57%, BMY belongs to the best of the industry, outperforming 93.17% of the companies in the same industry.
  • BMY has a Return On Invested Capital of 13.32%. This is amongst the best in the industry. BMY outperforms 90.73% of its industry peers.
  • The last Return On Invested Capital (13.32%) for BMY is above the 3 year average (9.56%), which is a sign of increasing profitability.
  • The Profit Margin of BMY (18.44%) is better than 92.68% of its industry peers.
  • BMY's Profit Margin has improved in the last couple of years.
  • BMY has a Operating Margin of 24.00%. This is amongst the best in the industry. BMY outperforms 92.68% of its industry peers.
  • With an excellent Gross Margin value of 76.70%, BMY belongs to the best of the industry, outperforming 82.44% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BMY has grown nicely.

Our Best Dividend screener lists more Best Dividend stocks and is updated daily.

Check the latest full fundamental report of BMY for a complete fundamental analysis.

Disclaimer

This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.

Back

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (4/19/2024, 7:04:00 PM)

After market: 48.93 0 (0%)

48.93

+0.63 (+1.3%)

BMY News

News Image2 days ago - Yahoo Finance3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations

These stocks pay between 3.2% and 6.7% in dividends.

News Image2 days ago - The Motley Fool3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations

These stocks pay between 3.2% and 6.7% in dividends.

News Image2 days ago - InvestorPlaceThese 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?

Small-cap stocks have been the market laggards but these standouts showed how to beat even top-tier tech names at their own game.

News Image3 days ago - The Motley FoolGot $500? 3 Healthcare Stocks to Buy and Hold Forever

Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.

News Image3 days ago - Yahoo FinanceGot $500? 3 Healthcare Stocks to Buy and Hold Forever

Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.

News Image4 days ago - AB NewswireNavigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
News Image4 days ago - InvestorPlace3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500

If you want to outperform the S&P 500, consider these undervalued dividend stocks for juicy yields and high total return potential.

News Image5 days ago - The Motley Fool2 High-Yield Dividend Stocks to Buy and Hold for 10 Years

These income stocks look like good options at current levels.

News Image6 days ago - InvestorPlace3 Pharma Stocks That Are Money-Printing Machines in 2024

The economy, and pharma industry, are projected to grow massively. You should invest in these top three pharma stocks.

News Image6 days ago - BusinessInsider3 Pharma Stocks That Are Money-Printing Machines in 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The future of the U.S. economy appears promising, with robust growth and strong...

News Image7 days ago - Investor's Business DailyNeumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug

The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.

News Image7 days ago - The Motley FoolBetter Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?

Bristol Myers Squibb stock sports an attractive valuation and dividend yield. Is it a more compelling buy than the Vanguard S&P 500 ETF?

BMY Links
Follow us for more